The medical management of reflux esophagitis. Role of antacids and acid inhibition.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Gastroenterology Clinics of North America

• Publication date

  1990-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 1977703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Propranolol steady-state pharmacokinetics are unaltered by omeprazole

  2004cited by this paper
• Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

  1990cited by this paper
• Reflux esophagitis in patients with Zollinger-Ellison syndrome.

  1990cited by this paper
• [Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].

  1989cited by this paper
• Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.

  1989cited by this paper
• Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.

  1989cited by this paper
• Epidemiology of oesophageal reflux disease.

  1989cited by this paper
• Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial

  1988cited by this paper
• The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis.

  1988cited by this paper
• Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

  1988cited by this paper
• Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.

  1988cited by this paper
• Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

  1988cited by this paper
• Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.

  1988cited by this paper
• The effects of omeprazole on gastro-oesophageal sphincter pressure, intragastric pH, and the migrating motor complex in fasting healthy subjects.

  1987cited by this paper
• Oral phenytoin pharmacokinetics during omeprazole therapy.

  1987cited by this paper
• Lack of effect of nizatidine on drug metabolism.

  1987cited by this paper
• Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial.

  1987cited by this paper
• Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.

  1987cited by this paper
• Famotidine: a notable lack of drug interactions.

  1987cited by this paper
• Intensive hospital monitoring study of intravenous cimetidine.

  1986cited by this paper
• The Hepatic and Renal Mechanisms of Drug Interactions with Cimetidine

  1986cited by this paper
• Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease.

  1986cited by this paper
• Antacids for peptic ulcer: do we have anything better?

  1986cited by this paper
• Dose-ranging in clinical trials: rationale and proposed use with placebo or positive controls.

  1986cited by this paper
• Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine.

  1986cited by this paper
• Healing and relapse of reflux esophagitis during treatment with ranitidine.

  1986cited by this paper
• A Critical Review of Current Medical Therapy for Gastroesophageal Reflux Disease

  1986cited by this paper
• Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease.

  1986cited by this paper
• Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.

  1986cited by this paper
• Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial.

  1985cited by this paper
• Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.

  1985cited by this paper
• Assessing the safety of drugs for the long-term treatment of peptic ulcers.

  1984cited by this paper
• Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis.

  1984cited by this paper
• Ranitidine in the treatment of symptomatic gastroesophageal reflux disease.

  1984cited by this paper
• Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.

  1984cited by this paper
• Omeprazole: effects on oxidative drug metabolism.

  1984cited by this paper
• Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

  1984cited by this paper
• Ranitidine and placebo in the treatment of reflux oesophagitis: A double‐blind randomized trial

  1983cited by this paper
• Aluminium hydroxide versus sucralfate as a phosphate binder in uraemia.

  1983cited by this paper
• Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis

  1983cited by this paper
• Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450.

  1983cited by this paper
• Cimetidine in the treatment of Zollinger-Ellison syndrome.

  1983cited by this paper
• Medical and surgical options in the management of patients with gastrinoma.

  1983cited by this paper
• Treatment of reflux oesophagitis with ranitidine.

  1983cited by this paper
• Diagnosis and management of the Zollinger-Ellison syndrome.

  1983cited by this paper
• Double-blind assessment of therapeutic efficacy in clinical trials

  1983cited by this paper
• Why do apparently healthy people use antacid tablets?

  1983cited by this paper
• Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.

  1983cited by this paper
• Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.

  1982cited by this paper
• Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study.

  1982cited by this paper
• Aluminium sucrose biscuit fillings to control hyperphosphataemia in patients undergoing dialysis.

  1981cited by this paper
• Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.

  1981cited by this paper
• Cimetidine for the Treatment of Symptomatic Gastro‐oesophageal Reflux

  1981cited by this paper
• Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons.

  1980cited by this paper
• Cimetidine, Metoclopramide, or Placebo in the Treatment of Symptomatic Gastroesophageal Reflux

  1980cited by this paper
• Controlled trial of cimetidine in reflux esophagitis

  1980cited by this paper
• Metabolic balance of aluminum studied in six men.

  1979cited by this paper
• CIMETIDINE IN THE TREATMENT OF REFLUX OESOPHAGITIS

  1979cited by this paper
• Cimetidine and gastric cancer.

  1979cited by this paper
• Adverse effects of aluminum-containing antacids on mineral metabolism.

  1979cited by this paper
• Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial.

  1978cited by this paper
• Quantitation of Gastroesophageal Reflux Before and After Therapy Using the Gastroesophageal Scintiscan

  1978cited by this paper
• Effect of cimetidine in symptomatic gastro-oesophageal reflux.

  1978cited by this paper
• Oral cimetidine in reflux esophagitis: a double blind controlled trial.

  1978cited by this paper
• A Multicentric, Randomized Clinical Trial of Gaviscon in Reflux Esophagitis

  1978cited by this paper
• Gastrointestinal absorption of aluminum from aluminum-containing antacids.

  1977cited by this paper
• Evidence of aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function.

  1977cited by this paper
• Symptomatic gastroesophageal reflux: Incidence and precipitating factors

  1976cited by this paper
• Medical and surgical management of reflux esophagitis. A 38-month report of a prospective clinical trial.

  1975cited by this paper
• Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin.

  1974cited by this paper
• The hiatus hernia-esophagitis-esophageal stricture complex. Twenty-year prospective study.

  1968cited by this paper

• Diagnosis and Management of Gastroesophageal Reflux Disease: A Concise Review for Clinicians.

  2025cites this paper
• Development and characterization of antacid microcapsules to buffer the acidic intervertebral disc microenvironment.

  2024cites this paper
• Association between use of antacid medications (proton pump inhibitors and histamine-2 receptor antagonists) and the incidence of lung cancer: A population-based cohort analysis

  2022cites this paper
• Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia

  2021influential citation
• Peptic ulcer disease

  2021cites this paper
• AKT question relating to child with a fever and rash

  2021cites this paper
• Comparative assessment of the physicochemical properties of antacid suspensions available in the Ho Municipality of the Volta Region of Ghana

  2021cites this paper
• Management of Gastroesophageal Reflux Disease: Surgical and Therapeutic Innovations

  2020cites this paper
• Foregut Surgery: Achalasia, Gastroesophageal Reflux Disease and Obesity

  2020influential citation
• Medical Treatment of GERD

  2019cites this paper
• Development and Validation of a Mucosal Impedance Contour Analysis System to Distinguish Esophageal Disorders.

  2019cites this paper
• Neurogenic Bowel Dysfunction and Gastrointestinal Problems

  2019cites this paper
• Proton pump inhibitor non-responsive gastroesophageal reflux disease: unraveling an enigma?

  2018cites this paper
• Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist.

  2018cites this paper
• Development of biomarkers for the risk stratification and targeted therapy of Barrett's oesophagus and oesophageal adenocarcinoma

  2018cites this paper
• Effects of Ramadan Fasting on the Symptoms of Gastroesophageal Reflux Disease

  2018cites this paper
• Evaluation of the clinical impact of concomitant acid suppression therapy in colorectal cancer patients treated with capecitabine monotherapy

  2018cites this paper
• Medical Treatment for GERD in Asia

  2018cites this paper
• Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.

  2018cites this paper
• Effectivity of the Nissen fundoplication and the influencing factors of the success Results at the Medical Centre of Pécs depending on the indications and symptoms

  2018cites this paper
• [Effectivity of the Nissen fundoplication and the influencing factors of the success. Results at the Medical Centre of Pécs depending on the indications and symptoms].

  2018cites this paper
• Gastroesophageal reflux disease: A clinical overview for primary care physicians.

  2017cites this paper
• Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin

  2017cites this paper
• Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients.

  2016cites this paper
• Effect of shakers exercise with kinesio taping in subjects withgastroesophageal reflux disease: A randomized controlled trial

  2016cites this paper
• The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis

  2016cites this paper
• Pharmacologic Therapies in Gastrointestinal Diseases.

  2016cites this paper
• Selective administration of domperidone in maintenance of homeostasis in human body

  2016cites this paper
• Gastroesophageal Reflux Disease

  2016cites this paper
• Current treatment of gastroesophageal reflux disease

  2015cites this paper
• Chemoprevention in Barrett's Esophagus: Current Status.

  2015cites this paper
• Manejo actual de la enfermedad por reflujo gastroesofágico

  2015cites this paper
• Chemoprevention in Barrett's oesophagus.

  2015cites this paper
• Tratamiento actual de la enfermedad por reflujo gastroesofágico

  2015cites this paper
• TITLE : Gastroesophageal Reflux Disease and the Otolaryngologic Manifestations SOURCE : Dept . of Otolaryngology , UTMB , Grand Rounds DATE : February 3 , 1999 RESIDENT PHYSICIAN : Jim

  2014cites this paper
• Reflux and acid peptic diseases in the elderly.

  2014cites this paper
• National consensus on the management of gastroesophageal reflux disease in Indonesia.

  2014cites this paper
• Normal esophageal physiology and laryngopharyngeal reflux.

  2013cites this paper
• On-Demand and Intermittent Therapy for Gastro-Oesophageal Reflux Disease

  2012cites this paper
• Long-term medical management of gastro-esophageal reflux disease: how long and when to consider surgery?

  2012cites this paper
• Circulating DNA markers of gastro-intestinal cancers

  2012cites this paper
• Management of Gastroesophageal Reflux Disease

  2012cites this paper
• Gastrointestinal symptoms and patient satisfaction more than 1 year after laparoscopic Nissen fundoplication

  2011cites this paper
• Review article: reflux in cough and airway disease

  2011cites this paper
• Differential diagnosis in allergy.

  2011cites this paper
• The impact of previous fundoplication on laparoscopic gastric bypass outcomes: a case-control evaluation

  2011cites this paper
• Gastroesophageal reflux disease.

  2011cites this paper
• Evaluation and treatment of laryngopharyngeal reflux symptoms.

  2011cites this paper
• Review article: reflux and its consequences – the laryngeal, pulmonary and oesophageal manifestations

  2011cites this paper
• Upper Aerodigestive Manifestations of Gastroesophageal Reflux Disease

  2010cites this paper
• Treatment of Laryngopharyngeal Reflux

  2009cites this paper
• GERD-Related Health Care Utilization, Therapy, and Reasons for Transfer of GERD Patients Between Primary Care Providers and Gastroenterologists in a US Managed Care Setting

  2009cites this paper
• Over-the-counter medication use in older adults.

  2008cites this paper
• Medical management of gastroesophageal reflux disease.

  2008cites this paper
• Effects of a single low dose of ranitidine and effervescent antacids on intragastric acidity in healthy volunteers.

  2007cites this paper
• On-Demand Therapy for Gastroesophageal Reflux Disease

  2007cites this paper
• Improving Pharmaceutical Care of the Elderly Patient With GERD

  2007cites this paper
• Lifestyle Modification Counseling in Patients With Gastroesophageal Reflux Disease

  2007cites this paper
• Endoluminal and transluminal surgery: current status and future possibilities

  2006cites this paper
• Gastroesophageal reflux disease in adults : the Kalixanda study: a population-based endoscopic study

  2006cites this paper
• The EAES Clinical Practice Guidelines on Laparoscopic Antireflux Surgery for Gastroesophagel Reflux Disease (1997)

  2006cites this paper
• Gastroesophageal Reflux Disease in the Elderly

  2006cites this paper
• Gastroesophageal reflux disease in bronchial asthma and the response to omeprazole.

  2005cites this paper
• Mechanisms of Disease: carcinogenesis in Barrett's esophagus

  2004cites this paper
• Managing Gastro-Oesophageal Reflux Disease in the Older Patient

  2004cites this paper
• Gastric and duodenal ulcers during pregnancy.

  2003cites this paper
• Diagnosis and management of reflux esophagitis.

  2003cites this paper
• Dysphagia in the Elderly

  2003cites this paper
• Management of gastroesophageal reflux disease.

  2003cites this paper
• Validation of a single-patient drug trial methodology for personalized management of gastroesophageal reflux disease.

  2002cites this paper
• Outcome of laparoscopic antireflux surgery in patients with nonerosive reflux disease

  2002cites this paper
• Wertigkeit der ösophagealen Langzeit-pH-Metrie bei der Beurteilung des gastro-ösophagealen Refluxes und seiner Komplikationen im Säuglings- und Kindesalter

  2001cites this paper
• Nonprescription Doses of Ranitidine Are Effective in the Relief of Episodic Heartburn

  2001cites this paper
• Review article: over‐the‐counter drugs and the gastrointestinal tract

  2001cites this paper
• Benign Esophageal Disease in the Elderly

  2001cites this paper
• Medical therapy for gastroesophageal reflux disease.

  2001cites this paper
• Rationale for surgical therapy of Barrett esophagus.

  2001cites this paper
• Guidelines for Evaluation and Treatment of Gastroesophageal Reflux in Infants and Children: Recommendations of the North American Society for Pediatric Gastroenterology and Nutrition

  2001cites this paper
• T ratamiento de la enfermedad por reflujo gastroesofágico

  2001cites this paper
• Current Treatment of Gastroesophageal-Esophagitis Reflux Disease

  2001cites this paper
• Selection of Patients for Laparoscopic Antireflux Surgery

  2001cites this paper
• Tratamiento del esófago de Barrett en el siglo XXI: controversias y perspectivas futuras

  2001cites this paper
• Motility-modifying agents and management of disorders of gastrointestinal motility.

  2000cites this paper
• GI Problems in Geriatric Patients

  2000cites this paper
• Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome.

  2000cites this paper
• Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux

  2000cites this paper
• Appropriateness of omeprazole prescribing in Quebec's senior population.

  2000cites this paper
• Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications.

  2000cites this paper
• Managing heartburn at the ‘base’ of the GERD ‘iceberg’: effervescent ranitidine 150 mg b.d. provides faster and better heartburn relief than antacids

  2000cites this paper
• Strategies for medical management of reflux disease.

  2000cites this paper
• Spontaneous gastroesophageal reflux and airway patency during the night in adult asthmatics.

  2000cites this paper
• [Role and limits of self-medication in the therapeutic strategy of gastroesophageal reflux in adults].

  1999cites this paper
• Low‐dose ranitidine for the relief of heartburn

  1999cites this paper
• Laparoscopic Anti-Reflux Surgery in the Community Hospital Setting: Evaluation of 100 Consecutive Patients

  1999cites this paper
• Valutazione economica del lansoprazolo nel trattamento dei pazienti affetti da reflusso esofageo

  1999cites this paper
• [Self-medication in gastroesophageal reflux: role and limits].

  1999cites this paper
• High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial

  1999cites this paper
• Determining the cost of gastroesophageal reflux disease: a decision analytic model.

  1998cites this paper
• Gastric and duodenal ulcers during pregnancy.

  1998cites this paper
• A Comparison of Retrospective and Concurrent Drug Utilization Review of Omeprazole

  1998cites this paper